NASDAQ · Drug Manufacturers - Specialty & Generic

InMed Pharmaceuticals Inc (INM)

$1.36 +2.26%

Add alert

50 In band Daily RSI (14) · 9 Oct 2026

Moving averages

SMA 200$1.18+15.25%

Company profile

InMed Pharmaceuticals Inc., a clinical-stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company is headquartered in Vancouver, Canada.

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

Market cap$7.09M

P/E ratioNone

EPS$-2.84

Beta0.978

Dividend yield0.00%

52-week high$2.50

52-week low$0.58

Similar stocks in Drug Manufacturers - Specialty & Generic

HIMS Hims & Hers Health Inc - Class A RSI 57 CGC Canopy Growth Corporation RSI 28 BFRI Biofrontera Inc RSI 36 TLRY Tilray Brands Inc - Class 2 RSI 33 LNTH Lantheus Holdings Inc RSI 48 ACB Aurora Cannabis Inc RSI 67 BCRX Biocryst Pharmaceuticals Inc RSI 49 ORGO Organogenesis Holdings Inc - Class A RSI 33 ZTS Zoetis Inc - Class A RSI 57 AQST Aquestive Therapeutics Inc RSI 52

Free forever

RSI alerts for INM

Get an email the moment InMed Pharmaceuticals Inc crosses into oversold or overbought territory. Nothing else, ever.

Add alert

Data last updated 13 September 2026 at 1:35 PM EDT